Χώρα: Κύπρος
Γλώσσα: Ελληνικά
Πηγή: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
TRAMADOL HYDROCHLORIDE
DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629
N02AX02
TRAMADOL
50MG
CAPSULE,HARD
TRAMADOL HYDROCHLORIDE (0022204882) 50MG
ORAL USE
Εθνική Διαδικασία
TRAMADOL
Νομικό καθεστώς: Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία; PACK WITH 10 CAPS IN BLISTER(S) (200041701) 10 CAPSULE - Εγκεκριμένο - Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία; PACK WITH 30 CAPS IN BLISTER(S) (200041702) 30 CAPSULE - Εγκεκριμένο - Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία
COMPARATIVE TABLE OF PIL-EN VS PIL-GR Package leaflet: Information for the user Tramadex 50 mg Capsules tramadol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Tramadex is and what it is used for 2. What you need to know before you take Tramadex 3. How to take Tramadex 4. Possible side effects 5. How to store Tramadex 6. Contents of the pack and other information 1. What Tramadex is and what it is used for Tramadol - the active substance in Tramadex - is a painkiller belonging to the class of opioids that acts on the central nervous Φύλλο οδηγιών χρήσης: Πληροφορίες για το χρήστη Tramadex 50 mg Καψάκια υδροχλωρική τραμαδόλη Διαβάστε προσεκτικά ολόκληρο το φύλλο οδηγιών χρήσης πριν αρχίσετε να παίρνετε αυτό το φάρμακο, διότι περιλαμβάνει σημαντικές πληροφορίες για σας. Φυλάξτε αυτό το φύλλο οδηγιών χρήσης. Ίσως χρειαστεί να το διαβάσετε ξανά. Εάν έχετε περαιτέρω απορίες, ρωτήστε τον γιατρό ή τον φαρμακοποιό σας. Η συνταγή για αυτό το φάρμακο χορηγήθηκε αποκλειστικά για σας. Δεν πρέπει να δώσετε το φάρμακο σε άλλους. Μπορεί να τους προκαλέσει βλάβη Διαβάστε το πλήρες έγγραφο
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT Tramadex 50 mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 50 mg tramadol hydrochloride. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Capsules. Light yellow, hard gelatin capsule, size 3, containing white to off-white granular powder. 4. CLINICAL INFORMATION 4.1 THERAPEUTIC INDICATIONS Treatment of moderate to severe pain. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology_ The dose should be adjusted to the intensity of the pain and the sensitivity of the individual patient. The lowest effective dose for analgesia should generally be selected. The total daily dose of 400 mg active substance should not be exceeded, except in special circumstances. Unless otherwise prescribed, Tramadex should be administered as follows: _Adults and adolescents aged 12 years and over_ ACUTE PAIN:_ _An initial dose of 100mg is usually necessary. This can be followed by doses of 50 or 100mg at 4 - 6 hourly intervals, and duration of treatment should be matched to clinical need (see section 5.1). PAIN ASSOCIATED WITH CHRONIC CONDITIONS: An initial dose of 50mg is advised and then titration according to pain severity. The need for continued treatment should be assessed at regular intervals as withdrawal symptoms and dependence have been reported (see section 4.4). _Children_ Tramadex capsules are not suitable for children below the age of 12 years. 1 _Geriatric patients_ A dose adjustment is not usually necessary in patients up to 75 years without clinically manifest hepatic or renal insufficiency. In elderly patients over 75 years elimination may be prolonged. Therefore, if necessary the dosage interval is to be extended according to the patient's requirements. _Renal insufficiency/dialysis and hepatic insufficiency_ In patients with renal and/or hepatic insufficiency the elimination of tramadol is delayed. In these patients prolongation of the dosage intervals should be carefully considered according to the pa Διαβάστε το πλήρες έγγραφο